Literature DB >> 27687732

Late-Onset Friedreich's Ataxia (LOFA) Mimicking Charcot-Marie-Tooth Disease Type 2: What Is Similar and What Is Different?

Rubens Paulo A Salomão1, Maria Thereza Drumond Gama1, Flávio Moura Rezende Filho1, Fernanda Maggi1, José Luiz Pedroso2, Orlando G P Barsottini1.   

Abstract

Herein, we report a patient that presented with late-onset progressive steppage gait, neuropathy and pes cavus, suggesting Charcot-Marie-Tooth (CMT) disease. Subsequent genetic investigation confirmed Friedreich's ataxia (FRDA). We demonstrate that late-onset Friedreich's ataxia (LOFA) may be a CMT mimicker. This case reinforces that other genetic conditions may clinically resemble CMT. The clinical similarities between CMT and FRDA include a symmetrical neuropathy (axonal in FRDA), steppage gait, and eventually scoliosis. We suggest that late-onset forms of hereditary neuropathies should be carefully evaluated, since LOFA may be a CMT mimicker.

Entities:  

Keywords:  Charcot–Marie–Tooth disease; Friedreich’s ataxia; Hereditary ataxias; hereditary neuropathies

Mesh:

Year:  2017        PMID: 27687732     DOI: 10.1007/s12311-016-0822-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  14 in total

1.  A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3.

Authors:  A Leal; B Morera; D Heuss; C Kayser; M Berghoff; R Villegas; E Hernández; M Méndez; H C Hennies; B Neundörfer; R Barrantes; A Reis; B Rautenstrauss
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

Review 2.  Update on Charcot-Marie-Tooth disease.

Authors:  Laurie Gutmann; Michael Shy
Journal:  Curr Opin Neurol       Date:  2015-10       Impact factor: 5.710

3.  Nonneurological Involvement in Late-Onset Friedreich Ataxia (LOFA): Exploring the Phenotypes.

Authors:  Alberto R M Martinez; Adriana Moro; Agessandro Abrahao; Ingrid Faber; Conrado R Borges; Thiago J R Rezende; Carlos R Martins; Mariana Moscovich; Renato P Munhoz; Sandra Leistner Segal; Walter O Arruda; Maria Luiza Saraiva-Pereira; Simone Karuta; José Luiz Pedroso; Anelyssa D'Abreu; Laura B Jardim; Íscia Lopes-Cendes; Orlando G Barsottini; Hélio A G Teive; Marcondes C França
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

Review 4.  Inherited neuropathies: clinical overview and update.

Authors:  Christopher J Klein; Xiaohui Duan; Michael E Shy
Journal:  Muscle Nerve       Date:  2013-06-26       Impact factor: 3.217

Review 5.  Milestones in Friedreich ataxia: more than a century and still learning.

Authors:  Agessandro Abrahão; José Luiz Pedroso; Pedro Braga-Neto; Edson Bor-Seng-Shu; Patricia de Carvalho Aguiar; Orlando Graziani Povoas Barsottini
Journal:  Neurogenetics       Date:  2015-02-08       Impact factor: 2.660

Review 6.  A practical approach to the genetic neuropathies.

Authors:  Alexander M Rossor; Matthew R B Evans; Mary M Reilly
Journal:  Pract Neurol       Date:  2015-04-21

Review 7.  Adult onset sporadic ataxias: a diagnostic challenge.

Authors:  Orlando Graziani Povoas Barsottini; Marcus Vinicius Cristino de Albuquerque; Pedro Braga-Neto; José Luiz Pedroso
Journal:  Arq Neuropsiquiatr       Date:  2014-03       Impact factor: 1.420

Review 8.  Clinical features and molecular genetics of autosomal recessive cerebellar ataxias.

Authors:  Brent L Fogel; Susan Perlman
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

Review 9.  Inherited peripheral neuropathies.

Authors:  Mario A Saporta; Michael E Shy
Journal:  Neurol Clin       Date:  2013-03-05       Impact factor: 3.806

10.  Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.

Authors:  Ahmed Bouhouche; Nazha Birouk; Hamid Azzedine; Ali Benomar; Garry Durosier; Dorothée Ente; Marie-Paule Muriel; Merle Ruberg; Ilham Slassi; Mohamed Yahyaoui; Odile Dubourg; Reda Ouazzani; Eric LeGuern
Journal:  Brain       Date:  2007-03-08       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.